$45.06
0.14% today
NYSE, Dec 30, 09:48 pm CET
ISIN
NL0012169213
Symbol
QGEN

QIAGEN NV Target price 2024 - Analyst rating & recommendation

QIAGEN NV Classifications & Recommendation:

Buy
65%
Hold
35%

QIAGEN NV Price Target

Target Price $51.50
Price $44.99
Potential
Number of Estimates 19
19 Analysts have issued a price target QIAGEN NV 2025 . The average QIAGEN NV target price is $51.50. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 23 analysts: 15 Analysts recommend QIAGEN NV to buy, 8 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the QIAGEN NV stock has an average upside potential 2025 of . Most analysts recommend the QIAGEN NV stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 1.97 1.98
8.23% 0.72%
EBITDA Margin 33.10% 35.00%
9.65% 5.73%
Net Margin 17.30% 4.98%
12.25% 71.22%

20 Analysts have issued a sales forecast QIAGEN NV 2024 . The average QIAGEN NV sales estimate is

$2.0b
Unlock
. This is
0.68% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.0b 1.31%
Unlock
, the lowest is
$2.0b 0.31%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $2.0b 8.23%
2024
$2.0b 0.72%
Unlock
2025
$2.1b 5.29%
Unlock
2026
$2.2b 6.63%
Unlock
2027
$2.4b 7.10%
Unlock
2028
$2.6b 7.45%
Unlock

19 Analysts have issued an QIAGEN NV EBITDA forecast 2024. The average QIAGEN NV EBITDA estimate is

$693m
Unlock
. This is
1.71% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$811m 19.04%
Unlock
, the lowest is
$308m 54.82%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $651m 17.08%
2024
$693m 6.50%
Unlock
2025
$765m 10.41%
Unlock
2026
$838m 9.50%
Unlock
2027
$884m 5.56%
Unlock
2028
$953m 7.78%
Unlock

EBITDA Margin

2023 33.10% 9.65%
2024
35.00% 5.73%
Unlock
2025
36.71% 4.89%
Unlock
2026
37.70% 2.70%
Unlock
2027
37.15% 1.46%
Unlock
2028
37.27% 0.32%
Unlock

7 QIAGEN NV Analysts have issued a net profit forecast 2024. The average QIAGEN NV net profit estimate is

$98.6m
Unlock
. This is
10.85% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$116m 30.01%
Unlock
, the lowest is
$81.9m 7.83%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $340m 19.47%
2024
$98.6m 71.02%
Unlock
2025
$431m 337.46%
Unlock
2026
$498m 15.57%
Unlock
2027
$552m 10.88%
Unlock
2028
$605m 9.44%
Unlock

Net Margin

2023 17.30% 12.25%
2024
4.98% 71.22%
Unlock
2025
20.69% 315.46%
Unlock
2026
22.42% 8.36%
Unlock
2027
23.21% 3.52%
Unlock
2028
23.64% 1.85%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 1.53 0.44
19.47% 71.24%
P/E 101.46
EV/Sales 5.26

7 Analysts have issued a QIAGEN NV forecast for earnings per share. The average QIAGEN NV <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.44
Unlock
. This is
10.00% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.52 30.00%
Unlock
, the lowest is
$0.37 7.50%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $1.53 19.47%
2024
$0.44 71.24%
Unlock
2025
$1.94 340.91%
Unlock
2026
$2.24 15.46%
Unlock
2027
$2.49 11.16%
Unlock
2028
$2.72 9.24%
Unlock

P/E ratio

Current 111.44 272.09%
2024
101.46 8.96%
Unlock
2025
23.19 77.14%
Unlock
2026
20.07 13.45%
Unlock
2027
18.10 9.82%
Unlock
2028
16.54 8.62%
Unlock

Based on analysts' sales estimates for 2024, the QIAGEN NV stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 5.30 0.38%
2024
5.26 0.68%
Unlock
2025
5.00 5.02%
Unlock
2026
4.69 6.21%
Unlock
2027
4.38 6.63%
Unlock
2028
4.07 6.94%
Unlock

P/S ratio

Current 5.08 0.72%
2024
5.04 0.67%
Unlock
2025
4.79 5.02%
Unlock
2026
4.49 6.21%
Unlock
2027
4.19 6.63%
Unlock
2028
3.90 6.94%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today